• 2762-49-4
    24-Methyl-Δ5-cholen-3β-ol-24-on
  • 1427208-57-8
    (3S,8S,9S,10R,13R,14S,17R)-17-((2R)-5-hydroxyhexan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
  • 参考文献

    SAGE THERAPEUTICS, INC.; UPASANI, Ravindra, B.; HARRISON, Boyd, L.; ASKEW, Benny, C. Jr.; DODART, Jean-Cosme; SALITURO, Francesco, G.; ROBICHAUD, Albert, J. Patent: WO2013/36835 A1, 2013

  • 上一页
  • 1
  • 2
  • 下一页